-

Asahi Kasei Receives 2025 TSMC Excellent Performance Award in Recognition of Its PIMEL™ Photosensitive Dielectric for Advanced Packaging Material

TOKYO--(BUSINESS WIRE)--Asahi Kasei received a 2025 TSMC Excellent Performance Award for “Excellent Technology Development and Production Support” in Advanced Packaging materials at the 2025 Supply Chain Management Forum held by Taiwan Semiconductor Manufacturing Co., Ltd. on November 25, 2025.

The award recognizes suppliers for their outstanding performance in the development of innovative technologies and production support for Advanced Packaging materials during the past year.

Nobuko Uetake, Senior Executive Officer of Asahi Kasei and key leader in the company’s electronics materials business, commented, “Our electronics business including PIMEL™ is positioned as First Priority in Asahi Kasei’s ‘Trailblaze Together’ medium-term management plan for fiscal 2025–2027. We have developed PIMEL™ products that meet diverse customer requirements by leveraging years of advanced technological expertise, and are making proactive investments to ensure stable supply, including the launch of a new plant. We look forward to continuing to support the rapidly evolving field of advanced semiconductors, especially for AI-related applications.”

About Asahi Kasei

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 50,000 employees worldwide, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Healthcare, Homes, and Material. For more information, visit www.asahi-kasei.com.

Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/.

Contacts

North America Contact:
Asahi Kasei America Inc.
Christian OKeefe
christian.okeefe@ak-america.com

Europe Contact:
Asahi Kasei Europe GmbH
Sebastian Schmidt
sebastian.schmidt@asahi-kasei.eu

Asahi Kasei

TOKYO:3407

Release Summary
Asahi Kasei received a 2025 TSMC Excellent Performance Award for “Excellent Technology Development and Production Support."
Release Versions

Contacts

North America Contact:
Asahi Kasei America Inc.
Christian OKeefe
christian.okeefe@ak-america.com

Europe Contact:
Asahi Kasei Europe GmbH
Sebastian Schmidt
sebastian.schmidt@asahi-kasei.eu

Social Media Profiles
More News From Asahi Kasei

Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen Production

TOKYO--(BUSINESS WIRE)--Asahi Kasei and P2H2 have signed an MOU to evaluate manufacturing scale-up and commercialization of water electrolysis systems using AEM technology....

Asahi Kasei Strengthens Carbon Footprint Transparency for Acrylonitrile Production with Independent Third-Party Verification

TOKYO--(BUSINESS WIRE)--Tongsuh Petrochemical, a subsidiary of Asahi Kasei, has obtained the “Reasonable Assurance” verification for the PCF of acrylonitrile (AN)....

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Inc., the global specialty pharmaceutical business of Tokyo-based Asahi Kasei, with U.S. and European business headquarters in Cary, North Carolina, today announced that the U.S. Food and Drug Administration (FDA) has approved HOVILPRI® (pritelivir) 100 mg tablets for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection that is refractory (with or without documented resistance) to treatment with acyclovir, valacy...
Back to Newsroom